Cover Image

CYP4 subfamily V member 2 (CYP4V2) polymorphisms were associated with ischemic stroke in Chinese Han population

Abstract Background CYP4 subfamily V member 2 (CYP4V2) polymorphisms are related to venous thromboembolism. However, the influence of CYP4V2 polymorphisms on the susceptibility to ischemic stroke (IS) remains undetermined. Methods We selected and genotyped five polymorphisms of CYP4V2 in 575 cases a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Faqing Long (Author), Desheng Wang (Author), Qingjie Su (Author), Yuhui Zhang (Author), Jianhong Li (Author), Shiliang Xia (Author), Hailun Wang (Author), Yongping Wu (Author), Qiumin Qu (Author)
Format:	Book
Published:	BMC, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8
by: Toshiro Niwa, et al.
Published: (2016)

Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke
by: Yuan Wu, et al.
Published: (2019)

Association of CYP7A1 and CYP2E1 Polymorphisms with Type 2 Diabetes in the Chinese Han Populations
by: Zhang L, et al.
Published: (2022)

CYP4V2 rs56413992 C > T was associated with the risk of coronary heart disease in the Chinese Han population: a case-control study
by: Kang Huang, et al.
Published: (2023)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
by: J. E. Zhang, et al.
Published: (2017)

Preferential expression of cytochrome CYP CYP2R1 but not CYP1B1 in human cord blood hematopoietic stem and progenitor cells
by: Shuoqi Xu, et al.
Published: (2014)

Effects of CYP3A4 Polymorphisms on Drug Addiction Risk Among the Chinese Han Population
by: Li Wang, et al.
Published: (2019)

Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China
by: Huang K, et al.
Published: (2023)

Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes-A Link in the Onset and Development of Cardiovascular Disease?
by: Benoit Drolet, et al.
Published: (2017)

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride
by: Diana María Campodónico, et al.
Published: (2022)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018)

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4
by: Mohamed Albadry, et al.
Published: (2024)

Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon
by: José Pereira de Moura Neto, et al.
Published: (2023)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
by: Fang-Ling Zhao, et al.
Published: (2022)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019)

<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction Predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2022)

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018)

High Frequency of CYP2A6*4, CYP2A6*7, and CYP2A6*9 Alleles Detected Among Patients with Type 2 Diabetic: Genetic Study in The Private Hospital in Yogyakarta
by: Christine Patramurti, et al.
Published: (2022)

Utilization of Human Liver Microsomes to Explain Individual Differences in Paclitaxel Metabolism by CYP2C8 and CYP3A4
by: Ryoko Taniguchi, et al.
Published: (2005)

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
by: Decker BS, et al.
Published: (2013)

Exploring the Effect of Compound Glycyrrhizin and Silybinin on the Metabolism of Pexidartinib in Rats Based on CYP3A4 and CYP2C9
by: Yanding Su, et al.
Published: (2023)

Characterisation of <it>CYP2C8</it>, <it>CYP2C9 </it>and <it>CYP2C19 </it>polymorphisms in a Ghanaian population
by: Dodoo Alexander NO, et al.
Published: (2009)

In vitro effects and in silico analysis of newly synthetized pyrrole derivatives on the activity of different isoforms of Cytochrome P450: CYP1A2, CYP2D6 and CYP3A4
by: Borislav Angelov, et al.
Published: (2022)

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro
by: Li-Li Zou, et al.
Published: (2023)

Case-control study on CYP4B1 gene polymorphism and susceptibility to gastric cancer in the chinese Han population
by: Shuyong Yu, et al.
Published: (2022)

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs
by: David Damoiseaux, et al.
Published: (2022)

Functional characterization of the defective CYP2C9 variant CYP2C9*18
by: Jian Liu, et al.
Published: (2021)

EFFECT OF HIGH SALT ON RENAL NKCC2 IN CYP4F2 transgenic mice
by: Yanyan Zhao, et al.
Published: (2012)

Regulation of X-Ray Irradiation on the Activity and Expression Levels of CYP1A2 and CYP2E1 in Rats
by: Xiang-Yang Li, et al.
Published: (2020)

Alpinetin suppresses CYP3A4, 2C9, and 2E1 activity in vitro
by: Hongming Song, et al.
Published: (2022)

Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism
by: Nicola Ferri, et al.
Published: (2023)

Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations
by: Sara Flores-Gutiérrez, et al.
Published: (2017)

Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells
by: Li H, et al.
Published: (2020)

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers
by: Shanshan Nie, et al.
Published: (2022)

POLYMORPHISM OF CYTOCHROME P450 2A6 (CYP2A6*1 AND CYP2A6*4) AMONG JAVANESE INDONESIAN SMOKER AND NON SMOKER
by: Christine Patramurti, et al.
Published: (2015)

The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics
by: Nadda Muhamad, et al.
Published: (2023)

Expression of CYP3A4 mRNA Is Correlated With CYP3A4 Protein Level and Metabolic Activity in Human Liver
by: Minoru Watanabe, et al.
Published: (2004)

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
by: Jim J. Xiao, et al.
Published: (2019)

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
by: Ingrid F. Metzger, et al.
Published: (2019)